Management of Gynecological Cancers

tibbi onkoloji ozel 13-4 kapak

Mehmet ARTAÇa

aNecmettin Erbakan Üniversitesi Meram Tıp Fakültesi, Tıbbi Onkoloji BD, Konya, TÜRKİYE

ABSTRACT
Studies related to gynecologic cancers after new treatments in recent years indicate that survival time increases in these cancers. However, despite all of these new developments, the improvement in survival rates in geriatric gynecologic cancer patients is much slower. Delayed and advanced stages in diagnosis, increased comorbidities, inadequate treatment despite poor tumor biology are among the causes of poor survival in elderly gynecological cancer patients. Management of gynecological cancers requires a multidisciplinary approach in all ages and conditions. Comprehensive Geriatric Assessment is a method in which international guidelines recommend routine use in elderly patients. In this review, management of treatment in elderly gynecologic cancer patients is discussed.
Keywords: Gynecologic neoplasms; elderly; management

Referanslar

  1. Sant M, Chirlaque Lopez MD, Agresti R, Sánchez Pérez MJ, Holleczek B, Bielska-Lasota M, et al. Survival women with cancers of breast and genital organs in Europe 1999- 2007: results of the EuROCARE-5 study. Eur J Cancer. 2015;51(15):2191-2205. [Crossref]  [PubMed]
  2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5-29. [Crossref]
  3. Gultekin M, Kucukyıldız I, Karaca MZ, Dundar S, Boztas G, Turan SH, et al. Int J Gynecol Cancer. 2017;27:S1-S9. [Crossref]  [PubMed]
  4. Dumas L, Ring A, Butler J, Kalsi T, Harari D, Banerjee S. Improving outcomes for older women with gynaecological malignancies. Cancer Treatment Reviews. 2016;50:99-108. [Crossref]  [PubMed]  [PMC]
  5. Sharma C,Deutsch I, Horowitz DP, Hershman DL, Lewin SN, Lu YS,et al. Patterns of care and treatment outcomes for elderly women with cervical cancer. Cancer. 2012;118(14):3618-26. [Crossref]  [PubMed]
  6. Hurria A, Togawa K, Mohile SG, Owusu C, Klepin HD, Gross CP, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011;29:3457-65. [Crossref]  [PubMed]  [PMC]
  7. Pope D, Ramesh H, Gennari R, Corsini G, Maffezzini M, Hoekstra HJ, et al. Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery. Surg Oncol. 2006;15:189-97. [Crossref]  [PubMed]
  8. Makary MA, Segev DL, Pronovost PJ, Syin D, Bandeen-Roche K, Patel P,et al. Fraility as a predictor of surgical outcomes in older patients. J Am Coll Surg. 2010;210:901-8. [Crossref]  [PubMed]
  9. Kanesvaran R, Li H, Koo KN, Poon D. Analysis of prognostic factors of comprehensive geriatric assessments and development of a clinical scoring system in elderly Asian patients with cancer.J Clin Oncol.2011;29:3620-7. [Crossref]  [PubMed]
  10. Dunne EF, unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS,et al. Prevalance of HPv infection among females in the united States. JAMA. 2007;297:813-9. [Crossref]  [PubMed]
  11. Tewari KS, Sill MW, Long HJ 3rd, Penson RT, Huang H, Ramondetta LM, et al. Incorporation of bevacuzimab in the treatment of recurrent and metastatic cervical cancer: a phase III randomized trial of the Gynecologic Oncology Group. N Engl J Med. 2014;370:734-43. [Crossref]  [PubMed]  [PMC]
  12. Kitagawa R, Katsumata N, Shibata T, Kamura T, Kasamatsu T, Nakanishi T et al. Paclitaxel plus carboplatin versus paclitaxel plus cisplatin in metastatic or recurrent cervical cancer: The open-label randomized phase III trial JCOG0505. J Clin Oncol. 2015;19:2129-35. [Crossref]  [PubMed]
  13. Magne N, Mancy NC, Chajon E, Duvillard P, Pautier P, Castaigne D, et al. Patterns of care and outcome in elderly cervical cancer patients: a special focus on brachytherapy. Radiother Oncol. 2009;91(2):197-201. [Crossref]  [PubMed]
  14. Setiawan vW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB, et al. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol. 2013;31:2607-18.
  15. Wright JD, Lewin SN, Barrena Medel NI, Sun X, Burke WM, Deutsch I, et al. Endometrial cancer in the oldest old: Tumor characteristics, patterns of care, and outcome. Gynecol Oncol. 2011;122:69-74. [Crossref]  [PubMed]
  16. Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, van't veer L, Garber JE, et al. Prophylactic oophorectomy in carriers of BRCA1 and BRCA2 mutations. N Engl J Med. 2002;346:1616-22. [Crossref]  [PubMed]
  17. Korc-Grodzicki B, Downey RJ, Shahrokni A, Kingham TP, Patel SG, Audisio RA. Surgical considerations in older adults with cancer. J Clin Oncol. 2014;32:2647-53. [Crossref]  [PubMed]
  18. Thrall MM, Golf BA, Symons RG, Flum DR, Gray HJ. Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderly. Obstet Gynecol. 2011; 118:537-47. [Crossref]  [PubMed]  [PMC]
  19. Hershman D, Jacobson JS, McBride R, Mitra N, Sundararajan v, Grann vR, et al. Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer. Gynecol Oncol. 2004;94:540-9. [Crossref]  [PubMed]
  20. Maas HA, Kruitwagen RF, Lemmens vE, Goey SH, Janssen-Heijnen ML. The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a populationbased study. Gynecol Oncol. 2005;97:104-9. [Crossref]  [PubMed]
  21. Pignata S, Breda E, Scambia G, Pisano C, Zagonel v, Lorusso D, et al. A phase II study of weekly carboplatin and paclitaxel as firstline treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study. Crit Rev Oncol Hematol. 2008;66:229-36. [Crossref]  [PubMed]
  22. Pignata S, Scambia G, Katsaros D, Gallo C, Pujade-Lauraine E, De Placido S, et al. Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial. Lancet Oncol 2014;15:396-405. [Crossref]  [PubMed]